Overview of Dr. Mitchell
Dr. Aaron Mitchell is an oncologist in New York, NY and is affiliated with Memorial Sloan-Kettering Cancer Center. He received his medical degree from New York University Grossman School of Medicine and has been in practice 5 years. He is one of 468 doctors at Memorial Sloan-Kettering Cancer Center who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2015 - 2018
Duke University HospitalResidency, Internal Medicine, 2011 - 2014
New York University School of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2021 - Present
NJ State Medical License 2019 - 2025
NY State Medical License 2018 - 2025
NC State Medical License 2011 - 2019
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
Costs to Medicare of Nonrecommended Bone-Modifying Agent Use for Castration-Sensitive Prostate Cancer.
Nemirovsky, D., Mishra Meza, A., Chakraborty, N., Persaud, S., Mitchell, A., Farooki, A., Morris, M.> ;JCO Oncology Practice. 2024 Jan 8Authors' reply to Laurent.
Winn, A., Mitchell, A.> ;BMJ. 2023 Dec 4- 5 citations
Pharmaceutical industry payments and delivery of non-recommended and low value cancer drugs: population based cohort study.
Aaron P Mitchell, Stacie B Dusetzina, Akriti Mishra Meza, Niti U Trivedi, Peter B Bach, Aaron N Winn> ;BMJ. 2023 Oct 25 - Join now to see all
Journal Articles
Function of BriC Peptide in the Pneumococcal Competence and Virulence Portfolio
Wenjie Xu, Aaron P Mitchell, PLoS One
Press Mentions
Study in India Could Make Immunotherapy More Affordable WorldwideNovember 22nd, 2022
Pharma-Funded FDA Gets Drugs Out Faster, but Some Work Only ‘Marginally’ and Most Are PriceySeptember 30th, 2022
F.D.A.’s Drug Industry Fees Fuel Concerns Over InfluenceSeptember 15th, 2022
- Join now to see all
Grant Support
- Functional Analysis Of Essential C. Albicans GenesNational Institute Of Allergy And Infectious Diseases2012
- Genetic Control Of C. Albicans Biofilm FormationNational Institute Of Allergy And Infectious Diseases2009–2012
- PROTEIN-PROTEIN Interaction Test In Candida AlbicansNational Institute Of Allergy And Infectious Diseases2009–2010
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of Allergy And Infectious Diseases2008–2010
- Large-Scale Analysis Of Candida Albicans Gene FunctionNational Institute Of Allergy And Infectious Diseases2008
- ASM Conference On Candida And CandidiasisNational Institute Of Allergy And Infectious Diseases2008
- Genetic Control Of C. Albicans Biofilm FormationNational Institute Of Allergy And Infectious Diseases2006–2008
- Molecular Mycology Summer CourseNational Institute Of Allergy And Infectious Diseases2003–2008
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of Allergy And Infectious Diseases2006–2007
- Large-Scale Analysis Of Candida Albicans Gene FunctionNational Institute Of Allergy And Infectious Diseases2004–2007
- 2006 Cellular &Molecular Fungal Biology Gordon Research ConferenceNational Institute Of Allergy And Infectious Diseases2006
- Training Program In Microbiology For Infectious DiseasesNational Institute Of Allergy And Infectious Diseases2004–2006
- C. Albicans Regulatory Pathways In Oral CandidiasisNational Institute Of Allergy And Infectious Diseases2001–2005
- New Strategies For Identification Of C. Albicans Fluconazole Resistance GeneNational Institute Of Allergy And Infectious Diseases2004
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of General Medical Sciences1995–2004
- Identification Of C Albicans Fluconazole Resistance GeneNational Institute Of Allergy And Infectious Diseases2003
- Identification And Evaluation Of Anti-Candida Vaccine TargetsNational Institute Of Allergy And Infectious Diseases1999–2002
- Genetic Control Of Entry Into Meiosis In YeastNational Institute Of General Medical Sciences1988–1994
